Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?

CONCLUSION: It is necessary to evaluate sarcopenia due to its impact on patient prognosis, and its utility in guiding patient management in metastatic breast cancer.PMID:34923226 | DOI:10.1016/j.breast.2021.12.014

Source: Breast - December 19, 2021 Category: Cancer & Oncology Authors: Elise Deluche Denis Lachatre Mario Di Palma H élène Simon Valentin Tissot Damien Vansteene Philippe Meingan Alexis Mohebi Gr égory Lenczner Francois Pigneur Francois Goldwasser Bruno Raynard SCAN Study Group Source Type: research